Figure 2.

The roles of nimotuzumab in tumor cells. Nimotuzumab can recognize and bind to extracellular domain of EGFR, which prevents the binding of ligands to receptor. Hence, EGFR signaling pathways is inhibited and this impairs tumor growth.